Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

por Webster, Lynn R, Israel, Robert J
Publicado 2018

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone

por Webster, Lynn R, Israel, Robert J
Publicado 2018

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical...

por Mehta, Neel, Slatkin, Neal E., Israel, Robert J., Stambler, Nancy
Publicado 2023

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

por Poulakou, Garyfallia, Barakat, Maxime, Israel, Robert J., Bacci, Marcelo R.
Publicado 2022

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

por Rauck, Richard L, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J
Publicado 2018

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

por Gottlieb, Alice, Lebwohl, Mark, Liu, Clive, Israel, Robert J., Jacobson, Abby
Publicado 2020

Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin

por DuPont, Herbert L., Wolf, Ray A., Israel, Robert J., Pimentel, Mark
Publicado 2016

Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation

por Farchadi, David, Slatkin, Neal E., Stambler, Nancy, Israel, Robert J., Matus, Michael
Publicado 2023

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose

por Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J
Publicado 2023

Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness

por Mehta, Neel, Slatkin, Neal E, Israel, Robert J, Stambler, Nancy, Shah, Eric D
Publicado 2023

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

por Webster, Lynn R., Michna, Edward, Khan, Arif, Israel, Robert J., Harper, Joseph R.
Publicado 2017

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies

por Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J
Publicado 2021

Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis

por Webster, Lynn R, Brenner, Darren, Israel, Robert J, Stambler, Nancy, Slatkin, Neal E
Publicado 2022

The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies

por Brenner, Darren M., Slatkin, Neal E., Stambler, Nancy, Israel, Robert J., Coluzzi, Paul H.
Publicado 2021

Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extensi...

por Bull, Janet, Wellman, Charles V., Israel, Robert J., Barrett, Andrew C., Paterson, Craig, Forbes, William P.
Publicado 2015

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

por Couroux, Peter, Brkovic, Alexandre, Vittitow, Jason L., Israel, Robert J., Pamidi, Chinna, Patel, Jignesh, Barakat, Maxime
Publicado 2022

Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials

por Shah, Eric D, Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neil E, Stambler, Nancy, Israel, Robert J
Publicado 2023

Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model

por Yuan, Chun-Su, Wang, Chong-Zhi, Mehendale, Sangeeta R, Aung, Han H, Foo, Adela, Israel, Robert J
Publicado 2009

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

por Fodor, Anthony A., Pimentel, Mark, Chey, William D., Lembo, Anthony, Golden, Pamela L., Israel, Robert J., Carroll, Ian M.
Publicado 2018

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

por Lebwohl, Mark G., Blauvelt, Andrew, Menter, Alan, Papp, Kim A., Guenthner, Scott, Pillai, Radhakrishnan, Israel, Robert J., Jacobson, Abby
Publicado 2019